Cargando…
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019
The differentiation between influenza and coronavirus disease 2019 (COVID-19) could constitute a diagnostic challenge during the ongoing winter owing to their clinical similitude. Thus, novel biomarkers are required to enable making this distinction. Here, we evaluated whether the surfactant protein...
Ejemplares similares
-
CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome
por: Choreño-Parra, Jose Alberto, et al.
Publicado: (2021) -
Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome
por: Choreño-Parra, Jose Alberto, et al.
Publicado: (2021) -
Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis
por: Choreño-Parra, José Alberto, et al.
Publicado: (2021) -
Differential Leukocyte Expression of IFITM1 and IFITM3 in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19
por: Regino-Zamarripa, Nora E., et al.
Publicado: (2022) -
Isolated agenesis of the corpus callosum and normal general intelligence development during postnatal life: a case report and review of the literature
por: Guadarrama-Ortiz, Parménides, et al.
Publicado: (2020)